Design and engineering of vesivax HIV immunogen formulations
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93024C00018
- Awardee
-
Molecular Express, Inc. UEI R1JMHFESEKD5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,999,866
Award facts
- Opportunity
-
- SBIRPHS20201 Solicitation number
- Contract value 100% obligated
- $1,999,866.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- CRYSTAL CITY, CA 90220, USA
- Research
- SBIR Program Phase II Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
This is a $1,999,866.00 Firm Fixed Price definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Molecular Express, Inc. for the design and engineering of Vesivax HIV immunogen formulations. The contract is a Total Small Business set-aside as part of the Small Business Innovation Research (SBIR) Program Phase II. Molecular Express is a minority-owned, self-certified small disadvantaged business specializing in developing innovative drug formulations, therapeutics, and vaccines, particularly in infectious diseases and respiratory illnesses. The company has previously received NIAID funding for Vesivax-based vaccine and adjuvant delivery system research targeting HIV, influenza, and other infectious diseases.
Quick answers
Who was awarded contract 75N93024C00018?
75N93024C00018 was awarded to Molecular Express, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 1, 2024.
How much is contract 75N93024C00018 worth?
The government has obligated $1,999,866 on 75N93024C00018.
Was contract 75N93024C00018 competed?
The extent of competition for 75N93024C00018 was full and open competition after exclusion of sources. The government received 2 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award